As previously reported, Piper Sandler analyst Jason Bednar initiated coverage of ICU Medical (ICUI) with an Overweight rating and $145 price target The infusion pump market faced regulatory and ...

In trading on Wednesday, shares of ICU Medical, Inc. (NASD: ICUI) crossed above their 200 day moving average of $66.17, changing hands as high as $66.20 per share.

ICU Medical beat analysts’ revenue expectations by 1% last quarter, reporting revenues of $589.1 million, up 6.5% year on year. It was a mixed quarter for the company, with an impressive beat of ...

View ICU Medical, Inc. ICUI stock quote prices, financial information, real-time forecasts, and company news from CNN.

ICU Medical’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $186.40 (compared to the current share price of $134.32).

ICU Medical starts off 2022 with the considerable task of integrating Smiths Medical. Operating synergies should provide a path to ICUI trading at 3.35x-3.5x sales in FY'24.

ICU Medical now looks to have a multiyear road to get that new business unit up to speed. In the second quarter of 2022, management cut its full-year adjusted EPS and EBITDA guidance range by ...

ICU Medical shares do look undervalued, but valuation of slow-growing small-cap medical device companies is tricky, and I'd prefer to see more evidence of stabilization and reacceleration.

What happenedShares of ICU Medical (NASDAQ: ICUI), a medical device company specializing in intravenous treatment solutions, were on the move today following the announcement of a cash and stock ...

My 10 years as an ICU nurse have shown me that futile care is confusing and traumatic for family members, demoralizing for doctors and nurses, and dehumanizing for patients.

ICU Medical Inc. ICUI 0.55% agreed to buy Pfizer Inc.’s infusion-systems business in a $1 billion cash-and-stock deal, giving the California medical-device maker a larger footprint in the global ...